Nektar Therapeutics Active Patents
121 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-07-12: Application 18221300; Invention MULTI-ARM POLYMER CONJUGATES OF TLR AGONIST COMPOUNDS AND RELATED IMMUNOTHERAPEUTIC TREATMENT METHODS; Applicant Nektar Therapeutics; Status Patented Case.
- 2023-02-27: Application 18114710; Invention CONJUGATES OF A FACTOR VIII MOIETY HAVING AN OXIME-CONTAINING LINKAGE; Applicant Nektar Therapeutics; Status Patented Case.
- 2021-11-30: Application 17538885; Invention POLYMERIC ALPHA-HYDROXY ALDEHYDE AND KETONE REAGENTS AND CONJUGATION METHOD; Applicant Nektar Therapeutics; Status Patented Case.
- 2021-11-03: Application 17608582; Invention ADENOSINE 2 RECEPTOR ANTAGONISTS; Applicant Nektar Therapeutics; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-12 | 18221300 | MULTI-ARM POLYMER CONJUGATES OF TLR AGONIST COMPOUNDS AND RELATED IMMUNOTHERAPEUTIC TREATMENT METHODS | Nektar Therapeutics | Patented Case | 2025-02-04 | 12214045 | US20230372500A1 | Zhongxu Ren Neel K. Anand Haiying Cai Bo-Liang Deng Bhalchandra V. Joshi Jonathan Zalevsky Takahiro Miyazaki Saul Kivimae | United States United States United States United States United States United Kingdom United States United States | CABRAL, ROBERT S |
| 2023-02-27 | 18114710 | CONJUGATES OF A FACTOR VIII MOIETY HAVING AN OXIME-CONTAINING LINKAGE | Nektar Therapeutics | Patented Case | 2025-06-10 | 12324828 | US20230241181A1 | Mary J. Bossard Dawei Sheng | United States United States | HEARD, THOMAS SWEENEY |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |